Karsten Krohn 
Anthracycline Chemistry and Biology II 
Mode of Action, Clinical Aspects and New Drugs

This series presents critical reviews of the present position and future trends in modern chemical research. It contains short and concise reports on chemistry, each written by the world renowned experts. The series is still valid and useful after five or ten years. More information as well as the electronic version of the whole content is available at: springerlink.com.

Table des matières

G.L. Beretta, F. Zunino: Molecular Mechanisms of Anthracycline Activity.- P. Menna, E. Salvatorelli, L. Gianni, G. Minotti: Anthracycline Cardiotoxicity.- M.L. Capobianco, C.V. Catapano: Daunomycin-TFO Conjugates for Downregulation of Gene Expression.- F. Kratz: Acid-Sensitive Prodrugs of Doxorubicin.- J.-C. Florent, C. Monneret: Doxorubicin Conjugates for Selective Delivery to Tumors.-
T.H. Koch, B.L. Barthel, B.T. Kalet, D.L. Rudnicki, G.C. Post, D.J. Burkhart: Anthracycline–Formaldehyde Conjugates and Their Targeted Prodrugs – F.-M. Arcamone: Sabarubicin.- M. Broggini: Nemorubicin